Home/Filings/4/0001628280-24-044631
4//SEC Filing

Freeman Robert Thomas 4

Accession 0001628280-24-044631

CIK 0001832466other

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 6:11 PM ET

Size

8.3 KB

Accession

0001628280-24-044631

Insider Transaction Report

Form 4
Period: 2024-10-29
Freeman Robert Thomas
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-10-31$12.04/sh36,197$435,982123,429 total(indirect: See Footnote)
  • Sale

    Common Stock

    2024-10-29$12.01/sh4,483$53,856159,626 total(indirect: See Footnote)
Holdings
  • Common Stock

    865,407
Footnotes (4)
  • [F1]Date of Rule 10b5-1 plan adoption: 03/15/2024
  • [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
  • [F3]Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.
  • [F4]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Issuer

Alignment Healthcare, Inc.

CIK 0001832466

Entity typeother

Related Parties

1
  • filerCIK 0001850414

Filing Metadata

Form type
4
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 6:11 PM ET
Size
8.3 KB